Results 121 to 130 of about 111,089 (390)
Advanced Science, EarlyView.Data from a prospective cohort with 112 auditory brainstem implant users are analyzed. Younger age at implantation (<3 years), less severe inner‐ear malformation (common cavity, cochlear aplasia, and hypoplasia), and more intraoperative eABR evoked electrodes (≥60%) are associated with better hearing and speech outcomes.
Yu Zhang +11 more
wiley +1 more source
Impact of Morbid Obesity on Left Ventricular Assist Device Support and Heart Transplantation [PDF]
, 2016 Morbidly obese patients requiring LVAD support encounter higher postoperative complications and wait longer for heart transplantation, however heart transplant and graft survival is comparable.
Cohen, Sophia, Tang, Daniel, MD
core +3 more sources
JACC: Heart Failure, 2017 More than 2,400 continuous-flow left ventricular assist devices (LVADs) are implanted each year in the United States alone. Both the number of patients living with LVADs and the life expectancy of these patients are increasing. As a result, patients with LVADs are increasingly encountered by non-LVAD specialists who do not have training in managing ...
Priyesh A. Patel +2 more
openaire +3 more sources
Genetics‐Based Targeting Strategies for Precise Neuromodulation
Advanced Science, Volume 12, Issue 28, July 24, 2025.In this Review, the fundamental principles and implementation protocols of genetics‐based precision neuromodulation are first introduced. Then, wireless and low‐invasive strategies based on nano‐transducing materials are highlighted, along with a dissection and analysis of the strengths and weaknesses of representative studies.
Yuyuan He +11 more
wiley +1 more source
American Heart Journal Plus, 2022 Background: Left ventricular assist device (LVAD) implantation provides a robust survival advantage, however despite improvements in mortality, the adverse event burden of durable mechanical circulatory support remains high.
Mustafa M. Ahmed +3 more
doaj
Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices [PDF]
, 2019 Background: The rising number of patients with a left ventricular assist device (LVAD) require care management to successfully transition home after implantation. These patients and their families need to manage their heart failure, and the complexities
Hirschman, Karen +3 more
core +1 more source
ESC Heart Failure, 2019 We aim to study the feasibility and clinical value of pulmonary artery pressure monitoring with the CardioMEMS™ device in order to optimize and guide treatment in patients with a HeartMate 3 left ventricular assist device (LVAD).
J. Veenis +13 more
semanticscholar +1 more source
Left ventricular-assist device arrest: total thrombosis of a continuous flow left ventricular-assist device [PDF]
European Heart Journal – Cardiovascular Imaging, 2015 A 46-year-old man with a continuous flow left ventricular-assist device implanted as destination therapy 2 years ago (CF-LVAD; HeartMate II, Thoratec Corporation, Pleasanton, CA, USA) presented with syncope, low flow device alarms, and several brief device stoppage events.
openaire +3 more sources
Advanced Science, EarlyView.Hydrogels hold great potential as candidates for next‐generation epidermal electronics; however, an unresolved issue remains: the differentiation and selection of sensing modes in hydrogel sensors. This study integrates series‐parallel conductive nanosheet configurations into an ultra‐soft hydrogel, resulting in enhanced signal intensity and ...
Shitao Shi +9 more
wiley +1 more source
CardioMEMS™ in LVAD Patients: A Case Series [PDF]
, 2016 Patients with a left ventricular assist device (LVAD) commonly encounter issues with volume status post-implant. Volume overload can result from incomplete compensation of left ventricular failure or from right ventricular failure.
Branam, Sarah +3 more
core +1 more source